药物信息为INCRELEX™ (mecasermin [rDNA origin] injection) (Tercica, Inc.): CONTRAINDICATIONS

INCRELEX™ should not be used for growth promotion in patients with closed epiphyses.

INCRELEX™ is contraindicated in the presence of active or suspected neoplasia, and therapy should be discontinued if evidence of neoplasia develops.

Intravenous administration of INCRELEX™ is contraindicated.

INCRELEX™ should not be used by patients who are allergic to mecasermin (IGF-1) or any of the inactive ingredients in INCRELEX™.